ATE497760T1 - Filmueberzug fuer tabletten und kapletten - Google Patents

Filmueberzug fuer tabletten und kapletten

Info

Publication number
ATE497760T1
ATE497760T1 AT03784379T AT03784379T ATE497760T1 AT E497760 T1 ATE497760 T1 AT E497760T1 AT 03784379 T AT03784379 T AT 03784379T AT 03784379 T AT03784379 T AT 03784379T AT E497760 T1 ATE497760 T1 AT E497760T1
Authority
AT
Austria
Prior art keywords
tablets
caplettes
film cover
dosage forms
coating compositions
Prior art date
Application number
AT03784379T
Other languages
English (en)
Inventor
Dominique Nicolas Cade
Ewart Thomas Cole
Frederic Jean Joseph Hoehn
Robert Anthony Scott
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of ATE497760T1 publication Critical patent/ATE497760T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Wrappers (AREA)
AT03784379T 2002-08-09 2003-07-30 Filmueberzug fuer tabletten und kapletten ATE497760T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02292020A EP1396263A1 (de) 2002-08-09 2002-08-09 Filmüberzüge für Tabletten oder Caplets
PCT/IB2003/003442 WO2004014344A1 (en) 2002-08-09 2003-07-30 Film coating for tablets and caplets

Publications (1)

Publication Number Publication Date
ATE497760T1 true ATE497760T1 (de) 2011-02-15

Family

ID=31502831

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03784379T ATE497760T1 (de) 2002-08-09 2003-07-30 Filmueberzug fuer tabletten und kapletten

Country Status (16)

Country Link
US (3) US7914820B2 (de)
EP (2) EP1396263A1 (de)
JP (2) JP4652052B2 (de)
CN (1) CN100500137C (de)
AT (1) ATE497760T1 (de)
AU (1) AU2003249464C1 (de)
BR (1) BR0313220A (de)
CA (1) CA2494045C (de)
DE (1) DE60335991D1 (de)
EA (1) EA007619B1 (de)
ES (1) ES2357949T3 (de)
MX (1) MXPA05001605A (de)
NZ (1) NZ537750A (de)
PT (1) PT1539114E (de)
SI (1) SI1539114T1 (de)
WO (1) WO2004014344A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1396263A1 (de) * 2002-08-09 2004-03-10 Warner-Lambert Company Filmüberzüge für Tabletten oder Caplets
EP2433621B1 (de) 2006-09-15 2013-05-01 Capsugel Belgium NV Schnell zerfallende Darreichungsform
US20080131467A1 (en) * 2006-11-30 2008-06-05 Dennis Nelson Film-coated solid dosage form
KR20140076621A (ko) * 2011-10-12 2014-06-20 다우 글로벌 테크놀로지스 엘엘씨 사출 성형된 투여형
WO2015187736A1 (en) * 2014-06-02 2015-12-10 Allergen Research Corporation Placebo formulations and uses thereof
WO2016105498A1 (en) 2014-12-23 2016-06-30 Synthetic Biologics, Inc. Methods and compositions for inhibiting or preventing adverse effects of oral antibiotics
CN111328284A (zh) 2017-08-07 2020-06-23 芬奇治疗公司 用于维持和恢复健康的肠道屏障的组合物和方法
EP3737750B1 (de) 2018-01-09 2024-06-05 Theriva Biologics, Inc. Alkalische phosphatasemittel zur behandlung von entwicklungsstörungen des nervensystems
CN112203669A (zh) 2018-02-23 2021-01-08 克雷斯顿沃控股公司 微生物组相关的免疫疗法
WO2019183209A1 (en) 2018-03-20 2019-09-26 Synthetic Biologics, Inc. Alkaline phosphatase agents for treatment of radiation disorders
ES3032290T3 (en) 2018-03-20 2025-07-16 Theriva Biologics Inc Intestinal alkaline phosphatase formulations
CN109535496A (zh) * 2018-11-13 2019-03-29 黄冈师范学院 一种可降解的透水性包衣膜的制备方法
CA3146738A1 (en) 2019-07-18 2021-01-21 Synthetic Biologics, Inc. Intestinal alkaline phosphatase-based treatments of metabolic disorders
AU2020316330A1 (en) 2019-07-19 2022-01-06 Finch Therapeutics Holdings Llc. Methods and products for treatment of gastrointestinal disorders
CA3154308A1 (en) 2019-09-13 2021-03-18 Mark Smith Compositions and methods for treating autism spectrum disorder
JP2022552005A (ja) 2019-10-18 2022-12-14 フィンチ セラピューティクス ホールディングス エルエルシー 細菌代謝産物を対象に送達するための組成物および方法
WO2021097288A1 (en) 2019-11-15 2021-05-20 Finch Therapeutics Holdings Llc Compositions and methods for treating neurodegenerative diseases
WO2021142358A1 (en) 2020-01-10 2021-07-15 Finch Therapeutics Holdings Llc Compositions and methods for treating hepatic encephalopathy (he)
WO2021142353A1 (en) 2020-01-10 2021-07-15 Finch Therapeutics Holdings Llc Compositions and methods for treating hepatitis b (hbv) and hepatitis d (hdv)
WO2021142347A1 (en) 2020-01-10 2021-07-15 Finch Therapeutics Holdings Llc Compositions and methods for non-alcoholic steatohepatitis (nash)
WO2021202806A1 (en) 2020-03-31 2021-10-07 Finch Therapeutics Holdings Llc Compositions comprising non-viable fecal microbiota and methods of use thereof
US12419322B2 (en) 2020-07-31 2025-09-23 Ferrara Candy Company Multi-texture confection
WO2022178294A1 (en) 2021-02-19 2022-08-25 Finch Therapeutics Holdings Llc Compositions and methods for providing secondary bile acids to a subject

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA753851B (en) * 1974-08-01 1976-05-26 Ici Ltd Film coating process
US5026560A (en) * 1987-01-29 1991-06-25 Takeda Chemical Industries, Ltd. Spherical granules having core and their production
MC2025A1 (fr) * 1988-04-20 1990-04-25 Asta Pharma Ag Medicament contenant de l'azelastine et capable de liberer celle-ci de facon controlee
GB2256648B (en) * 1991-05-29 1995-08-30 Colorcon Ltd Wax polish composition
JPH05144624A (ja) 1991-11-21 1993-06-11 Mitsubishi Steel Mfg Co Ltd 磁気記録媒体およびその製造方法
AU674840B2 (en) * 1992-01-17 1997-01-16 Bpsi Holdings, Inc. Film coatings and film coating compositions based on cellulosic polymers and lactose
TW237386B (de) * 1992-04-15 1995-01-01 Ciba Geigy
JPH06157325A (ja) * 1992-11-30 1994-06-03 Mitsubishi Kasei Corp 経口コレステロール低下剤
IL110014A (en) * 1993-07-01 1999-11-30 Euro Celtique Sa Solid controlled-release oral dosage forms of opioid analgesics
ES2150017T3 (es) * 1994-12-16 2000-11-16 Warner Lambert Co Proceso de encapsulacion de comprimidos en una capsula y formas de dosificacion solidas obtenidas por este proceso.
US6245350B1 (en) * 1994-12-16 2001-06-12 Warner-Lambert Company Process for encapsulation of caplets in a capsule and solid dosage forms obtainable by such process
ES2226128T3 (es) * 1997-06-11 2005-03-16 THE PROCTER & GAMBLE COMPANY Comprimido revestido con una pelicula para una seguridad del tracto gastrointestinal superior mejorada.
JP3677156B2 (ja) * 1997-09-05 2005-07-27 武田薬品工業株式会社 医薬
PA8466701A1 (es) * 1998-01-21 2000-09-29 Pfizer Prod Inc Comprimido de mesilato de trovafloxacino
US6432448B1 (en) 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
FR2795962B1 (fr) * 1999-07-08 2003-05-09 Prographarm Laboratoires Procede de fabrication de granules enrobes a gout masque et liberation immediate du principe actif
DE10033023A1 (de) * 2000-07-07 2002-01-31 Biogrund Gmbh Filmüberzugszusammensetzung auf Basis von Zellulosederivaten und Zuckeralkoholen
US6500457B1 (en) * 2000-08-14 2002-12-31 Peirce Management, Llc Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent
JP3885484B2 (ja) * 2000-11-07 2007-02-21 カシオ計算機株式会社 データ通信処理装置及び記録媒体
EP1396263A1 (de) * 2002-08-09 2004-03-10 Warner-Lambert Company Filmüberzüge für Tabletten oder Caplets
JP5144624B2 (ja) 2009-10-28 2013-02-13 京セラドキュメントソリューションズ株式会社 画像形成装置

Also Published As

Publication number Publication date
CN100500137C (zh) 2009-06-17
US20050249810A1 (en) 2005-11-10
EA200500074A1 (ru) 2005-08-25
JP4652052B2 (ja) 2011-03-16
JP2005539019A (ja) 2005-12-22
ES2357949T3 (es) 2011-05-04
EP1539114A1 (de) 2005-06-15
CA2494045A1 (en) 2004-02-19
CA2494045C (en) 2010-01-05
US20110142925A1 (en) 2011-06-16
BR0313220A (pt) 2005-06-14
MXPA05001605A (es) 2005-04-25
DE60335991D1 (de) 2011-03-24
US8557294B2 (en) 2013-10-15
US7914820B2 (en) 2011-03-29
AU2003249464B2 (en) 2008-09-25
CN1674876A (zh) 2005-09-28
EP1396263A1 (de) 2004-03-10
PT1539114E (pt) 2011-03-24
EA007619B1 (ru) 2006-12-29
AU2003249464A1 (en) 2004-02-25
JP2011026337A (ja) 2011-02-10
US20140105975A1 (en) 2014-04-17
EP1539114B1 (de) 2011-02-09
SI1539114T1 (sl) 2011-05-31
NZ537750A (en) 2007-09-28
WO2004014344A1 (en) 2004-02-19
AU2003249464C1 (en) 2009-03-05

Similar Documents

Publication Publication Date Title
ATE497760T1 (de) Filmueberzug fuer tabletten und kapletten
BR0307833A (pt) Sìntese controlada de ziprasidona e suas composições
EA200601555A1 (ru) Замещенные индазол-о-глюкозиды
BRPI0715579A2 (pt) "composto, composição farmacêutica e uso de um composto"
HUP0303886A3 (en) New film coating composition for coating of pharmaceutical compositions
EA200601554A1 (ru) Замещенные индол-о-глюкозиды
EA200601553A1 (ru) Замещенные бензимидазол-, бензтриазол- и бензимидазолон-о-глюкозиды
ATE433447T1 (de) Pyrimiidinverbindungen
SE0101675D0 (sv) Novel composition
MA31502B1 (fr) Anticorps anti-notch 1 specifiques a nrr et ses procedes d'utilisation
TW200740799A (en) Alpha2C adrenoreceptor agonists
UA86413C2 (ru) Сахарное покрытие и твердая дозированая форма, которая его содержит
BRPI0412659A (pt) isÈmero c de cci-779, seu processo de preparação, composição farmacêutica compreendendo o mesmo e pacote farmacêutico contendo o referido composto
EA200800240A1 (ru) Производные тиазола в качестве активатора амфк
BR0206595A (pt) Composto, composição farmacêutica, e uso de um composto
BR0318278A (pt) compostos de éter aminocicloexìlico e usos dos mesmo
NO20035442L (no) Pulverlakksammensetning
CL2007002619A1 (es) Compuestos derivados de 3-aza-biciclo[4.1.0]heptano; composicion farmaceutica; y uso en el tratamiento de la depresion.
GEP20084519B (en) 3-(4-heteroarylcyclo-hexylamino) cyclopenta-necarboxamides as modulators of chemokine receptors
TW200738659A (en) Novel compounds
EA200702589A1 (ru) 2,6-хинолинильные производные, способы их получения и их применение
BRPI0512820A (pt) composição de matéria, e método de revestir um metal
BR0212353A (pt) Composto, composição farmacêutica, e, uso de um composto
DK1730147T3 (da) Substituerede 1,4,8-triazaspiro[4.5]decan-2-on-forbindelser til behandling af fedme
UA87335C2 (en) Gel composition of 4-hydroxytamoxifen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1539114

Country of ref document: EP